Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03280303
Other study ID # A5481082
Secondary ID POLARIS
Status Completed
Phase
First received
Last updated
Start date January 4, 2017
Est. completion date December 22, 2022

Study information

Verified date July 2023
Source Pfizer
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.


Recruitment information / eligibility

Status Completed
Enrollment 1285
Est. completion date December 22, 2022
Est. primary completion date October 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria 1. Age =18 years or older. 2. Diagnosis of adenocarcinoma of the breast with evidence of metastatic disease or advanced disease not amenable to treatment with curative intent. 3. Documented HR+ (ER+ and/or PR+) tumor based on local standards. 4. Documented HER2- tumor based on local standards. 5. Physician has determined that treatment with palbociclib is indicated. 6. Evidence of a personally signed and dated informed consent document indicating that the patient has been informed of all pertinent aspects of the study. 7. Patients who in the opinion of the investigator are willing and able to comply with regular clinic visits as per standard of care practice at the site. Exclusion Criteria: 1. Patients with a life expectancy of less than 3 months at the time of ABC diagnosis, per the investigator's judgment. 2. Patients participating in any interventional clinical trial that includes investigational or marketed products at the time of enrollment. (Patients participating in other investigator initiated research or NIS can be included as long as their standard of care is not altered by the study). 3. Patients on active treatment for malignancies other than ABC at the time of enrollment. 4. Patients who are unable to understand the nature of the study and are unwilling to sign an informed consent. -

Study Design


Intervention

Other:
non-interventional


Locations

Country Name City State
Canada Burnaby Hospital Cancer Centre Burnaby British Columbia
Canada Integrated University Center for Health and Social Services (CIUSSS) of Saguenay-Lac Saint Jean Chicoutimi Quebec
Canada Trillium Health Partners Mississauga Ontario
Canada St. Michael's Hospital Toronto Ontario
United States Alabama Oncology Alabaster Alabama
United States Texas Oncology -Allen Allen Texas
United States St. Luke's Hospital - Allentown Campus Allentown Pennsylvania
United States St. Luke's University Health Network - Sacred Heart Hospital Allentown Pennsylvania
United States McFarland Clinic, P.C. Ames Iowa
United States Virginia Cancer Specialists Arlington Virginia
United States Illinois Cancer Specialists Arlington Heights Illinois
United States Asheville Hematology and Oncology Asheville North Carolina
United States Sutter Auburn Auburn California
United States Rocky Mountain Cancer Centers Aurora Colorado
United States Northwest Georgia Oncology Centers, PC Austell Georgia
United States AIS Cancer Center at Adventist Health Bakersfield Bakersfield California
United States Mercy Clinic St. Louis Cancer and Breast Institute Ballwin Missouri
United States Greater Baltimore Medical Center Baltimore Maryland
United States Mercy Medical Center Baltimore Maryland
United States Mary Bird Perkins Cancer Center Baton Rouge Louisiana
United States Our Lady of the Lake Physician Group, Louisiana Hematology Oncology Associates Baton Rouge Louisiana
United States Our Lady of the Lake Regional Medical Center Baton Rouge Louisiana
United States Our Lady of the Lake Regional Medical Center, Oncology 6 Baton Rouge Louisiana
United States Alabama Oncology Bessemer Alabama
United States Maryland Oncology and Hematology, PA Bethesda Maryland
United States St. Luke's Hematology Oncology Specialists Bethlehem Pennsylvania
United States St. Luke's Hematology Oncology Specialists Bethlehem Pennsylvania
United States St. Luke's University Heatlh Network Bethlehem Pennsylvania
United States Beverly Hills Cancer Center Beverly Hills California
United States Alabama Oncology Birmingham Alabama
United States Alabama Oncology Birmingham Alabama
United States Alabama Oncology Birmingham Alabama
United States Alabama Oncology Birmingham Alabama
United States Grandview Cancer Center, Alabama Oncology Birmingham Alabama
United States The University of Alabama at Birmingham Birmingham Alabama
United States University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama
United States Boca Raton Regional Hospital/Lynn Cancer Institute Boca Raton Florida
United States Florida Cancer Research Institute Boca Raton Florida
United States Massachusetts General Hospital Boston Massachusetts
United States Rocky Mountain Cancer Centers Boulder Colorado
United States Presence St. Mary's Cancer Center Bourbonnais Illinois
United States CareMount Medical Brewster New York
United States West Virginia University Medicine - United Hospital Center Bridgeport West Virginia
United States St. Louis Cancer Care, LLP Bridgeton Missouri
United States Wellmont Bristol Regional Medical Center Bristol Tennessee
United States Wellmont Medical Associates Oncology and Hematology Bristol Tennessee
United States Wellmont Medical Associates Oncology and Hematology Bristol Virginia
United States Providence Health and Services Southern California Burbank California
United States Fairview Ridges Hospital Burnsville Minnesota
United States Hematology Oncology Associates, Inc. Canton Ohio
United States Mercy Medical Center Canton Ohio
United States Northwest Georgia Oncology Centers, PC Carrollton Georgia
United States Northwest Georgia Oncology Centers, PC Cartersville Georgia
United States Oncology Associates at Mercy Medical Center Cedar Rapids Iowa
United States Charleston Cancer Center Charleston South Carolina
United States University of Tennessee/Erlanger Oncology and Hematology Chattanooga Tennessee
United States Cancer Specialists of Tidewater/Riverside Cancer Infusion Center Chesapeake Virginia
United States St. Louis Cancer Care, LLP Chesterfield Missouri
United States The Office of Frederick P. Smith, MD Chevy Chase Maryland
United States Presence Saint Joseph Hospital Chicago Illinois
United States Enloe Regional Cancer Center Chico California
United States Johnston Health Services Corporation - Clayton Clayton North Carolina
United States Maryland Oncology Hematology, P.A. Clinton Maryland
United States Haywood Infusion Center Clyde North Carolina
United States Rocky Mountain Cancer Centers Colorado Springs Colorado
United States Boone Hospital Center Columbia Missouri
United States Maryland Oncology Hematology, P.A. Columbia Maryland
United States Missouri Cancer Associates Columbia Missouri
United States Mid Ohio Oncology/Hematology, Inc. dba The Mark H. Zangmeister Center Columbus Ohio
United States John Muir Clinical Research Center Concord California
United States John Muir Medical Center, Concord Campus Concord California
United States Mount Diablo Solano Oncology Group Concord California
United States Minnesota Oncology Hematology, PA Coon Rapids Minnesota
United States Pontchartrain Cancer Center Covington Louisiana
United States North Shore Oncology Hematology Associates Crystal Lake Illinois
United States North Shore Oncology-Hematology Associates Crystal Lake Illinois
United States Texas Oncology Dallas Texas
United States Western Connecticut Health Network Danbury Connecticut
United States Texas Oncology-Denton South Denton Texas
United States Rocky Mountain Cancer Centers Denver Colorado
United States Rocky Mountain Cancer Centers Denver Colorado
United States Northwest Georgia Oncology Centers, PC Douglasville Georgia
United States Tri-County Hematology and Oncology Associates, Inc. Dover Ohio
United States Gwinnett Hospital System, Inc. Duluth Georgia
United States Gwinnett Hospital System, Inc. The Center for Cancer Care Duluth Georgia
United States Greenville Health System Easley South Carolina
United States New York Cancer and Blood Specialists East Setauket New York
United States St. Luke's University Heatlh Network Easton Pennsylvania
United States Fairview Southdale Hospital Edina Minnesota
United States Fairview Southdale Medical Oncology Clinic Edina Minnesota
United States Texas Oncology-El Paso Cancer Treatment Center El Paso Texas
United States Willamette Valley Cancer Institute and Research Center Eugene Oregon
United States Presence Infusion Care - Evanston Evanston Illinois
United States Virginia Cancer Specialists Fairfax Virginia
United States Cape Fear Valley Health System Fayetteville North Carolina
United States Cape Fear Valley Health System Fayetteville North Carolina
United States Augusta Health Cancer Center Fishersville Virginia
United States Cancer Specialists of North Florida Fleming Island Florida
United States Southeast Florida Hematology-Oncology Group, PA Fort Lauderdale Florida
United States Texas Oncology Fort Worth Texas
United States Texas Oncology - Fort Worth Cancer Center Fort Worth Texas
United States Texas Oncology - Southwest Fort Worth Fort Worth Texas
United States Maryland Oncology Hematology, P.A. Frederick Maryland
United States Virginia Cancer Specialists Gainesville Virginia
United States Tidelands Waccamaw Oncology/Georgrtown Hospital System Georgetown South Carolina
United States Global Cancer Research Institute, Inc. Gilroy California
United States Peninsula Cancer Institute/Riverside Cancer Infusion Center Gloucester Virginia
United States Colorado West Healthcare System, dba Community Hospital Grand Junction Colorado
United States Colorado West Healthcare System, dba Grand Valley Oncology Grand Junction Colorado
United States East Carolina University Brody School of Medicine Greenville North Carolina
United States Greenville Health System Greenville South Carolina
United States Greenville Health System Greenville South Carolina
United States Greenville Health System Greer South Carolina
United States Great Lakes Cancer Management Grosse Pointe Woods Michigan
United States Hackensack University Medical Center, John Theurer Cancer Center Hackensack New Jersey
United States Antietam Oncology and Hematology Group, PC Haggerstown Maryland
United States Pontchartrain Cancer Center Hammond Louisiana
United States Pinnacle Health Cancer Center Harrisburg Pennsylvania
United States Pinnacle Health Cancer Institute Harrisburg Pennsylvania
United States DLP Maria Parham Medical Center Henderson North Carolina
United States Advent Health - Hendersonville Hendersonville North Carolina
United States University of North Carolina Regional Physicians Hematology Oncology High Point North Carolina
United States MD Anderson Cancer Center Houston Texas
United States Texas Oncology Houston Texas
United States Huntington Internal Medicine Group Huntington West Virginia
United States St. Mary's Medical Center Huntington West Virginia
United States Cancer Specialists LLC Jacksonville Florida
United States Cancer Specialists of North Florida Jacksonville Florida
United States Cancer Specialists of North Florida Jacksonville Florida
United States Cancer Specialists of North Florida Jacksonville Florida
United States Cancer Specialists of North Florida Jacksonville Florida
United States Cancer Specialists of North Florida Jacksonville Florida
United States University of Florida Health Jacksonville Florida
United States Wellmont Medical Associates Oncology and Hematology Johnson City Tennessee
United States Joliet Oncology-Hematology Associates, LTD Joliet Illinois
United States St. Luke's Cancer Institute Kansas City Missouri
United States St. Luke's Cancer Institute - East Kansas City Missouri
United States Novant Health Oncology Specialists Kernersville North Carolina
United States Wellmont Cancer Institute Kingsport Tennessee
United States Wellmont Holston Valley Medical Center Kingsport Tennessee
United States Breastlink Medical Group, Inc. Laguna Hills California
United States Watson Clinic Lakeland Florida
United States Rocky Mountain Cancer Centers Lakewood Colorado
United States Carolina Blood and Cancer Care Associates, PA Lancaster South Carolina
United States Lancaster Cancer Center Lancaster Pennsylvania
United States Duke Cancer Network Laurinburg North Carolina
United States Gwinnett Hospital System Inc. Lawrenceville Georgia
United States Gwinnett Hospital System, Inc. The Center for Cancer Care Lawrenceville Georgia
United States Virginia Cancer Specialists Leesburg Virginia
United States St. Luke's Cancer Institute - Liberty Liberty Missouri
United States Advocate Condell Medical Center Libertyville Illinois
United States North Shore Oncology-Hematology Associates Libertyville Illinois
United States Nebraska Hematology/Oncology, PC Lincoln Nebraska
United States Central Arkansas Radiation Therapy Institute Little Rock Arkansas
United States Rocky Mountain Cancer Centers Littleton Colorado
United States Rocky Mountain Cancer Centers Lone Tree Colorado
United States Rocky Mountain Cancer Centers Longmont Colorado
United States University Medical Center Health System, Southwest Cancer Center Lubbock Texas
United States Southeastern Regional Medical Center Lumberton North Carolina
United States University of Minnesota Health Maple Grove Clinics Maple Grove Minnesota
United States Northwest Georgia Oncology Centers, PC Marietta Georgia
United States Cancer Center at West Jefferson Medical Center, New Orleans Physician Services, Inc. Marrero Louisiana
United States Crescent City Research Consortium, LLC Marrero Louisiana
United States Tri-County Hematology and Oncology Associates, Inc. Massilon Ohio
United States Texas Oncology McAllen Texas
United States Texas Oncology - McKinney McKinney Texas
United States Ortenzio Cancer Center at Pinnacle Health Mechanicsburg Pennsylvania
United States Bon Secours Memorial Regional Medical Center, Inc. Mechanicsville Virginia
United States Bon Secours Richmond Community Hospital dba Oncology Associates at Memorial Regional Medical Center Mechanicsville Virginia
United States Texas Oncology Mesquite Texas
United States East Jefferson General Hospital Metairie Louisiana
United States Baptist Health Medical Group Oncology, LLC Miami Florida
United States Baptist Health Miami Cancer Institute Miami Florida
United States Miami Cancer Institute at Baptist Health, Inc. Miami Florida
United States Cancer Specialists of North Florida - St. Vincent's Clay Middleburg Florida
United States Bon Secours Cancer Institute @ St. Francis Medical Center Midlothian Virginia
United States Bon Secours Richmond Community Hospital dba Oncology Associates at St. Francis Medical Center Midlothian Virginia
United States Bon Secours St. Francis Medical Center, Inc. Midlothian Virginia
United States Minnesota Oncology Hematology, PA Minneapolis Minnesota
United States West Virginia University, Mary Babb Randolph Cancer Center Morgantown West Virginia
United States Joliet Oncology-Hematology Associates, LTD Morris Illinois
United States Novant Health Oncology Specialists Mount Airy North Carolina
United States CareMount Medical Mount Kisco New York
United States Northern Westchester Hospital Mount Kisco New York
United States Tidelands Waccamaw Oncology/Georgrtown Hospital System Murrells Inlet South Carolina
United States Tidelands Waccamaw Oncology/Georgrtown Hospital System Myrtle Beach South Carolina
United States Riverside Shore Cancer Center Nassawadox Virginia
United States Joliet Oncology-Hematology Associates, LTD New Lenox Illinois
United States Western Connecticut Health Network New Milford Connecticut
United States Touro Infirmary New Orleans Louisiana
United States Oncology Hematology Associates of Southwest Indiana Newburgh Indiana
United States Breastlink Medical Group, Inc. Newport Beach California
United States Peninsula Cancer Institute/Riverside Cancer Infusion Center Newport News Virginia
United States New England Hematology Oncology/Massachusetts General Cancer Center at Newton Wellesley Hospital Newton Massachusetts
United States Mid Illinois Hematology And Oncology Associates, Limited Normal Illinois
United States University of Kansas Cancer Center North Kansas City Missouri
United States Novant Health Oncology Specialists North Wilkesboro North Carolina
United States Southwest Virginia Regional Cancer Center Norton Virginia
United States Western Connecticut Health Network Norwalk Connecticut
United States Breastlink Medical Group, Inc. Orange California
United States The Valley Hospital Paramus New Jersey
United States Texas Oncology-Paris Paris Texas
United States Rocky Mountain Cancer Centers Parker Colorado
United States Camden Clark Medical Center Parkersburg West Virginia
United States New York Cancer and Blood Specialists Patchogue New York
United States Millennium Oncology Research Clinic/Hematology and Oncology Private Practice Pembroke Florida
United States Mercy Health Perrysburg Cancer Center Perrysburg Ohio
United States St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare Petaluma California
United States St. Luke's University Heatlh Network - Warren Hospital Phillipsburg New Jersey
United States Texas Oncology Plano Texas
United States Baptist Health Miami Cancer Institute Plantation Florida
United States Florida Cancer Research Institute Plantation Florida
United States Diablo Valley Oncology Hematology Medical Group Pleasant Hill California
United States Epic Care Pleasant Hill California
United States New York Cancer and Blood Specialists Port Jefferson Station New York
United States Northwest Cancer Specialists, PC Portland Oregon
United States Northwest Cancer Specialists, PC Portland Oregon
United States Delta Hematology/Oncology Associates Portsmouth Virginia
United States Portsmouth Regional Hospital Portsmouth New Hampshire
United States Rocky Mountain Cancer Centers Pueblo Colorado
United States Quincy Medical Group Quincy Illinois
United States Bon Secours Richmond Community Hospital dba Oncologists Associates at St. Mary's Hospital Richmond Virginia
United States Bon Secours St. Mary's Hospital, Inc. Richmond Virginia
United States New York Cancer and Blood Specialists Riverhead New York
United States Carolina Blood and Cancer Care Associates, PA Rock Hill South Carolina
United States Maryland Oncology Hematology, P.A. Rockville Maryland
United States Sutter Roseville Medical Center Roseville California
United States Northwest Georgia Oncology Centers, PC Roswell Georgia
United States Sutter Institute for Medical Research Sacramento California
United States Cancer Specialists of North Florida Saint Augustine Florida
United States St. Helena Hospital Saint Helena California
United States Heartland Regional Medical Center/dba Cancer Care St. Joseph Mosaic Life Care Saint Joseph Missouri
United States Mercy Clinic St. Louis Cancer and Breast Institute Saint Louis Missouri
United States Mercy Hospital St. Louis Saint Louis Missouri
United States Mercy Research - Mercy Heart Hospital St. Louis Saint Louis Missouri
United States SSM Health St. Louis University Hospital Saint Louis Missouri
United States St. Louis Cancer Care, LLP Saint Louis Missouri
United States St. Louis University Cancer Center Saint Louis Missouri
United States Health Partners Institute Saint Louis Park Minnesota
United States Metro-Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota
United States Park Nicollet Frauenshuh Cancer Center Saint Louis Park Minnesota
United States Minnesota Oncology Hematology, PA Saint Paul Minnesota
United States Regions Hospital Saint Paul Minnesota
United States Regions Hospital Cancer Care Center Saint Paul Minnesota
United States Salinas Valley Medical Clinic Cancer Care Salinas California
United States Salinas Valley Memorial Healthcare System Salinas California
United States Texas Oncology San Antonio Texas
United States Texas Oncology-San Antonio Downtown San Antonio Texas
United States Texas Oncology-San Antonio Stone Oak San Antonio Texas
United States Santa Clara Valley Medical Center San Jose California
United States Cancer Research Collaboration/Breastlink Medical Group, Inc. Santa Ana California
United States Ridley Tree Cancer Center Santa Barbara California
United States SANSUM Clinic Santa Barbara California
United States St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare Santa Rosa California
United States Candler Medical Oncology Practice (CMOP) Savannah Georgia
United States Candler Medical Oncology Practice (CMOP)/Summit Cancer Care Savannah Georgia
United States Summit Cancer Care Research Savannah Georgia
United States Seattle Cancer Care Alliance Seattle Washington
United States Greenville Health System Seneca South Carolina
United States Maryland Oncology Hematology, P.A. Silver Spring Maryland
United States Maryland Oncology Hematology, P.A. Silver Spring Maryland
United States Orchard Healthcare Research Inc. Skokie Illinois
United States Presence Infusion Care - Skokie Skokie Illinois
United States Johnston Health Services Corporation - Smithfield Smithfield North Carolina
United States New York Cancer and Blood Specialists Smithtown New York
United States Gwinnett Hospital System, Inc. The Center for Cancer Care Snellville Georgia
United States Sansum Clinic Solvang California
United States Greenville Health System Spartanburg South Carolina
United States Spartanburg Regional Medical Center Spartanburg South Carolina
United States Willamette Valley Cancer Institute and Research Center Springfield Oregon
United States Novant Health Oncology Specialists Statesville North Carolina
United States Lakeview Hospital Stillwater Minnesota
United States St. Joseph's Medical Center Stockton California
United States Stockton Hematology Oncology Medical Group Stockton California
United States Central Arkansas Radiation Therapy Institute Stuttgart Arkansas
United States Cancer Specialists of Tidewater/Riverside Cancer Infusion Center Suffolk Virginia
United States M. Francisco Gonzalez, MD, PA Sumter South Carolina
United States Baptist Health Urgent Care Sawgrass Sunrise Florida
United States Novant Health Oncology Specialists Thomasville North Carolina
United States Rocky Mountain Cancer Centers Thornton Colorado
United States Mercy Health Cancer Center Toledo Ohio
United States Mercy Health St. Vincent Medical Center Toledo Ohio
United States Stormont Vail Cotton O'Neill Cancer Center Topeka Kansas
United States Stormont Vail Regional Health Center Topeka Kansas
United States University of Maryland St. Joseph Medical Center Towson Maryland
United States Munson Medical Center Traverse City Michigan
United States North Mississippi Medical Center, Inc., Hematology and Oncology Research Tupelo Mississippi
United States Texas Oncology Tyler Texas
United States Cancer Treatment Center of Vacaville Vacaville California
United States Solano Hematology Oncology Vallejo California
United States Northwest Cancer Specialists, PC Vancouver Washington
United States Cancer Specialists of Tidewater/Riverside Cancer Infusion Center Virginia Beach Virginia
United States Contra Costa Oncology Walnut Creek California
United States John Muir Medical Center, Walnut Creek Camous Walnut Creek California
United States Great Lakes Cancer Management Warren Michigan
United States Mercy Health Youngstown dba St Joseph Warren Hospital Warren Ohio
United States MedStar Washington Hospital Center Washington District of Columbia
United States University of Kansas Cancer Center Westwood Kansas
United States White Plains Hospital White Plains New York
United States Peninsula Cancer Institute/Riverside Cancer Infusion Center Williamsburg Virginia
United States Rice Memorial Hospital Willmar Minnesota
United States Novant Health Oncology Specialists Winston-Salem North Carolina
United States Minnesota Oncology Hematology, PA Woodbury Minnesota
United States University of Massachusetts Memorial Medical Center Worcester Massachusetts
United States Mercy Health Youngstown dba St. Elizabeth Youngstown Hospital Youngstown Ohio

Sponsors (1)

Lead Sponsor Collaborator
Pfizer

Countries where clinical trial is conducted

United States,  Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical outcome Progression free survival: the time from the start date of palbociclib to the date of the progression of disease or death according to investigator's assessment Reporting will be based on sample size and follow up time through 2022.
Primary Patient quality of life, as measured by EORTC QLQ-C30 EORTC QLQ-C30 is used to assess changes in quality of life for patients undergoing treatment for cancer. It is a 30-item questionnaire assessing other cancer-related symptoms, with responses based on recall during the past week. Reporting will be based on sample size and follow up time through 2022.
Primary Geriatric Assessments in patients equal to or greater than 70 years of age at enrollment, as assessed by G8 Screening Tool The G8 Screening Tool is a physician-assessed tool to identify geriatric cancer patients for comprehensive geriatric assessment to evaluate an older person's functional ability, physical health, cognition and mental health, and socioenvironmental circumstances. Reporting will be based on sample size and follow up time through 2022.
Primary Geriatric Assessments in patients equal to or greater than 70 years of age at enrollment, as assessed by Activities of Daily Living Activities of daily living assesses patient basic self-care skills to maintain independence in home (bathing, dressing toileting, feeding oneself, maintain continent, transferring from bed/chair). Reporting will be based on sample size and follow up time through 2022.
Primary Biomarker Assessment Exploratory research question for investigating potential mechanism of response and resistance to palbociclib treatment, through genomic analyses in the blood samples collected at standard of care intervals. Reporting will be based on sample size and follow up time through 2022.
See also
  Status Clinical Trial Phase
Withdrawn NCT04872608 - A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer Phase 1
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Completed NCT02506556 - Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer Phase 2
Recruiting NCT05534438 - A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer Phase 2
Recruiting NCT03368729 - Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer Phase 1/Phase 2
Completed NCT04103853 - Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer Phase 1
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Active, not recruiting NCT03147287 - Palbociclib After CDK and Endocrine Therapy (PACE) Phase 2
Not yet recruiting NCT06062498 - Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer Phase 2
Recruiting NCT05383196 - Onvansertib + Paclitaxel In TNBC Phase 1/Phase 2
Recruiting NCT04095390 - A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer Phase 2
Active, not recruiting NCT04432454 - Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation Phase 2
Recruiting NCT03323346 - Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer Phase 2
Recruiting NCT05744375 - Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab Phase 2
Completed NCT02924883 - A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy Phase 2
Completed NCT01942135 - Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) Phase 3
Completed NCT01881230 - Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) Phase 2/Phase 3
Active, not recruiting NCT04448886 - Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC Phase 2
Completed NCT01401959 - Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy Phase 2
Terminated NCT04720664 - Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer Phase 2